Ayala Alfred
Division of Surgical Research, Department of Surgery, Brown University Health-Rhode Island Hospital and the Alpert School of Medicine at Brown University, Providence, RI, USA.
J Leukoc Biol. 2025 Aug 5;117(8). doi: 10.1093/jleuko/qiaf108.
When I think about scientific/professional "legacy," for me there are at least 3 areas to consider: 1) the actual scientific legacy you (and your lab members) have contributed to, 2) the people you have touched and how they touch you in this scientific journey, and 3) what professional impact you left on the scientific/academic community. So, with that in mind, I will try to share my (our lab groups') story relative to our contributions to the delineation of various mechanisms that appear to contribute to the development of immune suppression and/or organ injury resultant from shock and/or septic insult by weaving in and out of the science over the past ∼35 yr, while digressing from the pure science at certain places in hope of giving you some personal/professional context that effected this individual's (lab groups') scientific journey. Inasmuch, please appreciate that the science discussed will be more of a summary of the contributions we think we may have made (appreciating as possible the contributions of colleagues in the field that spoke to such findings) relative to the understanding of the mechanisms of immune suppression in shock/sepsis and will not be a deep dive into the specific data sets.
当我思考科学/专业“遗产”时,对我来说至少有三个方面需要考虑:1)你(以及你的实验室成员)所做出贡献的实际科学遗产;2)你所接触的人以及他们在这段科学旅程中如何影响你;3)你对科学/学术社区产生的专业影响。所以,基于此,我将尝试分享我(我们实验室团队)的故事,讲述我们在过去约35年里如何通过穿梭于科学研究之中,为阐明各种似乎导致休克和/或脓毒症损伤引起的免疫抑制和/或器官损伤发展的机制做出贡献,同时在某些地方偏离纯粹的科学内容,希望能给你一些影响这个人(实验室团队)科学旅程的个人/专业背景信息。因此,请理解所讨论的科学内容更多是我们认为我们可能做出的贡献的总结(尽可能认识到该领域同事对这些发现的贡献),涉及对休克/脓毒症中免疫抑制机制的理解,而不会深入探讨具体的数据集。